While single-drug inhibition of NF-κB had little long-term effectiveness in repressing the anchorage-independent growth of TSC2(−) AML cells, we observed a marked reduction in colony size with combined treatment with NF-κB/mTOR inhibitors, which persisted after removal of both drugs. The gene discussed is TSC2; the disease is acute myeloid leukemia.